-
About FDA
-
CDER Archives
Official records, older publications and superseded but still useful information. This classification is currently under development and is not comprehensive.
- CDER Freedom of Information Office Electronic Reading Room Contact FOI directly to obtain information not available on the CDER web site.
- FDA Drug Approval Packages. (Drugs@FDA)
- Synthetic Generic Conjugated Estrogens. CDER announced that it will not approve synthetic generic forms of the estrogen-replacement drug Premarin.
Archival Reports & Publications
- CDER 2005 Report to the Nation: Improving Public Health Through Human Drugs (PDF - 495 KB)
- MS Powerpoint slides (220 kb): graphs in report for use in presentations.
- CDER 2004 Report to the Nation: Improving Public Health Through Human Drugs (PDF - 109 KB)
- CDER 2003 Report to the Nation: Improving Public Health Through Human Drugs (PDF - 196 KB)
- MS PowerPoint Slides (134 KB): Graphs in report for use in presentations.
- CDER 2002 Report to the Nation: Improving Public Health Through Human Drugs (PDF - 196 KB)
- MS Powerpoint slides (134 kb): Graphs in report for use in presentations.
- CDER 2001 Report to the Nation: Improving Public Health Through Human Drugs (PDF - 633 KB)
- MS PowerPoint Slides (156 KB). Graphs in report for use in presentations.
- CDER 2000 Report to the Nation: Improving Public Health Through Human Drugs (PDF - 663 KB)
- MS PowerPoint Slides (203 KB). Graphs in report for use in presentations.
- Mifepristone (Mifeprex) Index of Redacted Documents
- FDA's Drug Review and Approval Times
-
-